Berkshire Asset Management’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,102
Closed -$236K 221
2022
Q2
$236K Sell
1,102
-199
-15% -$42.6K 0.02% 205
2022
Q1
$369K Buy
1,301
+531
+69% +$151K 0.02% 154
2021
Q4
$290K Buy
+770
New +$290K 0.02% 203